Jan 23 (Reuters) - Sun Pharmaceutical Industries, India's top drugmaker by revenue, said on Friday it has received regulatory ...

Democrats are ahead of Republicans by 6 percentage points on a generic congressional ballot, according to a new poll. In the ...

You won't have to explain your plans in detail every time you start a search, as AI Mode can connect to Gmail and Google ...

Indian drugmaker Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized ...

Tasting Table tried Joanna Gaines' line of frozen Magnolia Table baked goods at Target and there was one item that our tester ...

Their camaraderie and chemistry as well as the Michael Mann-style vibe save what is essentially a predictable film.

NEW DELHI — In the global pursuit of greater pharmaceutical accessibility, Indian generic drugs have gained popularity for their affordability and broad reach, while also facing persistent challenges ...

Jan 23 () - Sun ​Pharmaceutical ‌Industries, India's ‌top drugmaker by ⁠revenue, ‌said on Friday ‍that it has ​received ‌regulatory approval to manufacture and sell ⁠generic ​semaglutide ​in India.

Sun Pharmaceutical Industries announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection.

Approval clears the regulatory path for a lower-cost GLP-1 weight-loss drug in India, but commercial launch hinges on semaglutide patent expiry.

Mohammed Ali Naqvi's Sundance-premiering doc chronicles a dramatic 2023 gondola accident in rural Pakistan.